
Nicoya Lifesciences to Further Develop Alto SPR Platform, Enter International Markets
December 21, 2021

Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry
December 16, 2021

Nicoya Lifesciences to receive up to $2 million in response to the Point of Care and Home Diagnostic Kit for COVID-19 challenge
May 26, 2021

Rapid detection of COVID-19 and its variants: Nicoya develops innovative saliva test kit
May 7, 2021

Nicoya Lifesciences receives additional funding for next-phase development of its rapid, saliva-based COVID-19 diagnostic test
Apr 06, 2021

Nicoya receives over $1.9M in funding to continue the development of a portable, saliva-based COVID-19 test
Mar 29, 2021

Nicoya Provides Complimentary Surface Plasmon Resonance Support for Researchers During COVID-19
April 30, 2020

Nicoya Launches Alto, the World’s First Digital Benchtop SPR System, to Accelerate Drug Discovery
January 23, 2020

FedDev Ontario announces a contribution of $2.57 million for Nicoya’s scale-up operations
May 3, 2019

Nicoya Lifesciences raises $2 million to change how the next generation of drugs will be discovered
January 31, 2018